DOI: 10.25881/20728255_2023_18_2_143

Authors

Hanaliev B.V., Barsegyan A.G., Azizov R.M., Kosarev E.I.

Pirogov National Medical and Surgical Center, Moscow

Abstract

A clinical observation of a patient with urolithiasis with a stone in the lower third of the ureter against the background of severe prostatic hyperplasia is presented. The peculiarity of this clinical case lies in the intraoperative picture during the operation, in the gradual complication of both the underlying and concomitant diseases that may occur during the operation.

Keywords: benign prostatic hyperplasia, urolithiasis, ureteral stone, contact lithotripsy.

References

1. Apolihin OI, Sivkov AV, Moskaleva NG, Solnceva TV, Komarova VA. Analiz uronefrologicheskoj zabolevaemosti i smertnosti v Rossijskoj Federacii za desyatiletnij period (2008-2018) po dannym oficial’noj statistiki. Eksperimental’naya i klinicheskaya urologiya. 2019; 2: 2-12. (In Russ.)

2. Dosaeva LA, SHatohina SN, SHilov EM. Diagnostika, medikamentoznoe lechenie i profilaktika mochekamennoj bolezni. Klinicheskaya medicina. 2017; 1: 21-27. (In Russ.)

3. Zemchenkov AYU, Tomilina NA. K/DOKI obrashchaetsya k istokam hronicheskoj pochechnoj nedostatochnosti (o novom razdele Rekomendacij K/DOQI po diagnostike, klassifikacii i ocenke tyazhesti hronicheskih zabolevanij pochek). Nefrologiya i dializ. 2016; 6(3): 204-220. (In Russ.)

4. Unnikrishnan R, Almassi N, Fareed K. Benign prostatic hyperplasia: evaluation and medical management in primary care. Cleve Clin J Med. 2017; 84: 53-64. doi: 10.3949/ccjm.84a.16008.

5. Il’yash AV., CHibichyan MB., Kogan MI. Rak predstatel’noj zhelezy, vyyavlennyj pri operativnom lechenii adenomy. Urologiya. 2012; 1: 54-58. (In Russ.)

6. Na R, Helfand BT, Chen H, Conran CA, Crawford SE, Hayward SW, Tammela T, Hoff man-Bolton J, Zheng SL, Walsh PC, Schleutker J, Platz EA, Isaacs WB, Xu J. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Prostate. 2017; 77: 1213-1220. doi:10.1002/pros.23380.

7. Qian X, Liu H, Xu D, Xu L, Huang F, He W, Qi J, Zhu Y, Xu D. Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and meta-analysis. Aging Male. 2017; 20(3): 184-191. doi:10.1080/13685538.2017.1295436.

8. Rieken M, Kaplan SA. Enucleation, Vaporization, and Resection: How To Choose the Best Surgical Treatment Option for a Patient with Male Lower Urinary Tract Symptoms. Eur Urol Focus. 2018; 4(1): 8-10. doi:10.1016/j.euf.2018.04.020.

For citation

Hanaliev B.V., Barsegyan A.G., Azizov R.M., Kosarev E.I. Contact ureterolithotripsy for severe prostatic hyperplasia. Bulletin of Pirogov National Medical & Surgical Center. 2023;18(2):143-145. (In Russ.) https://doi.org/10.25881/20728255_2023_18_2_143